BN Business News
Add your company to Business Communicator →

Business · 25/08/2023Updated: 10/17/2026 · 1 min read

FDA Proposes Withdrawal of Approval for Cancer Treatment PEPAXTO

Summary

The FDA is seeking public comment on its plan to withdraw approval of PEPAXTO, a cancer treatment, due to concerns about its safety and efficacy, and is expected to make a final decision by a certain date.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →